AbClonal Science, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2040
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for T4 DNA ligase variants with increased resistance to salt (US 11,685,913) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 2 fees due Mar 5 to 26, 2027 · next Mar 5
- 2 fees due Apr 10 to 17, 2027 · next Apr 10
- 1 fee due May 21, 2027The maintenance fee for Mutant Taq Polymerase for Faster Amplification (US 11,821,010) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Nov 17 US 12,799,515 T7 DNA Ligase Variant, R129D, with Increased Specificity for Cohesive End Polynucleotides
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,865,441 | Mutant Taq Polymerase for Faster Amplification In force · High confidence | In force | High confidence | |
| US 11,168,312 | Mutant taq polymerase for amplification in increased salt concentration or body fluids In force · USPTO record | In force | USPTO record | |
| US 11,613,738 | Mutant Taq Polymerase Resistant to Inhibition of Amplification in the Presence of Cyanine Dye In force · High confidence | In force | High confidence | |
| US 11,649,441 | Taq DNA Polymerase Mutants for Probe qPCR In force · High confidence | In force | High confidence | |
| US 11,821,010 | Mutant Taq Polymerase for Faster Amplification In force · High confidence | In force | High confidence | |
| US 12,258,590 | Mutant Taq Polymerase Providing Faster Amplification In force · High confidence | In force | High confidence | |
| US 12,467,040 | Mutant Taq polymerase for increased salt concentration or body fluids In force · USPTO record | In force | USPTO record | |
| US 10,920,202 | Thermolabile Serratia Marcescens nuclease In force · USPTO record | In force | USPTO record | |
| US 11,020,474 | Producing Recombinant SARS-CoV-2 Spike Protein in a Pre-fusion State In force · High confidence | In force | High confidence | |
| US 11,421,019 | Binding Agents to Pre-Fusion State SARS-COV-2 Spike Protein In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 3 no status recorded
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/309,682 | Aug 26, 2025 | No status recorded | |
| 19/068,241 | Mutant Taq Polymerase for Fast Speed Amplification | Mar 3, 2025 | Pending |
| 18/789,578 | Jul 30, 2024 | No status recorded | |
| 18/780,632 | Jul 23, 2024 | No status recorded | |
| 18/418,226 | T7 DNA Ligase Variants Having Increased Ligation Efficiency | Jan 20, 2024 | Pending |
| 18/073,598 | T4 DNA Ligase Variants with Increased Ligation Efficiency | Dec 2, 2022 | Pending |